KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Research & Development (2016 - 2025)

Idexx Laboratories has reported Research & Development over the past 17 years, most recently at $66.8 million for Q4 2025.

  • Quarterly results put Research & Development at $66.8 million for Q4 2025, up 15.77% from a year ago — trailing twelve months through Dec 2025 was $251.2 million (up 14.29% YoY), and the annual figure for FY2025 was $251.2 million, up 14.29%.
  • Research & Development for Q4 2025 was $66.8 million at Idexx Laboratories, up from $63.4 million in the prior quarter.
  • Over the last five years, Research & Development for IDXX hit a ceiling of $123.2 million in Q2 2022 and a floor of $37.6 million in Q1 2021.
  • Median Research & Development over the past 5 years was $49.9 million (2022), compared with a mean of $53.9 million.
  • Biggest five-year swings in Research & Development: soared 226.87% in 2022 and later plummeted 62.26% in 2023.
  • Idexx Laboratories' Research & Development stood at $45.3 million in 2021, then decreased by 4.17% to $43.4 million in 2022, then rose by 19.33% to $51.8 million in 2023, then rose by 11.42% to $57.7 million in 2024, then rose by 15.77% to $66.8 million in 2025.
  • The last three reported values for Research & Development were $66.8 million (Q4 2025), $63.4 million (Q3 2025), and $61.9 million (Q2 2025) per Business Quant data.